Home l Contact us l Feedback l Sitemap     
Introduction
9/11 Rx |Seminars | Sleep Apnea | ZHT for Apnea | Investors l Partners l Providers | Disclaimer | About us
Sleep Apnea Linked to top 10 Medical killings as Main Public Health Risk and Concerns
 

Sleep apnea, sleep-disordered breathing, and intermittent hypoxia have been identified and linked in latest research to almost all major fatal medical conditions, from heart attack, stroke, diabetes, COPD cancer, and major depressive disorders.

Current main-stream treatment options are unsatisfactory, and the entire world is looking for a better or best solution.

This market is one of the most explosive and largely untapped markets.

SleepApneaUSA.net, founded by Dr. Jin Zhou, relied upon the latest research and clinically developed ZHT - Zhou's Hypoxicology Therapy to discover a possible cure for sleep apnea and provide an alternative care to those who can't tolerate CPAP,"sleeping mask".

 
We are looking for visionary investors, strategic partners, business alliance and concerned healthcare providers to advance our goals, to find and provide with possible cure for sleep apnea, and its related major fatal medical conditions.

This web site is mainly for visionary investors, strategic business partners and concerned healthcare providers.





ZHT in News Introduction What Is ZHT? ZHT History Science for ZHT ZHT, Sex & Heart Clinical Applications ZHT Unlimited ZHT Future ZHT for USA
Introduction:
Sleep Apnea & ZHT - Zhou's Hypoxicology Therapy


Sleep apnea, sleep-disordered breathing, and intermittent hypoxia have been identified and linked in latest research to almost all major fatal medical conditions, from heart attack, stroke, diabetes, COPD cancer, and major depressive disorders.

What is ZHT?

Zhou’s Hypoxicology Therapy (ZHT) was pioneered/developed by Dr. Jin Zhou, DC, in late 2004. It is a new medical clinical concept of etiology, pathophysiology and clinical therapy, which identifies Trachea Caudal Displacement (TCD) & Vocal Cord dysfunction (VCD) induced chronic intermittent hypoxia through Silent Upper Airway Resistance Syndrome (SUARS) and Frequent & Recurrent Upper Airway Collapse Syndrome (FRUACS) or sleep-disordered breathing, as well as nocturnal gastroesophageal reflux (NGER) as a new fundamental physio-pathological mechanism, as one of the main causes, for mild to moderate but prolonged hypoxia for most illness & diseases for worldwide mortality and disability, from pain & arthritis, heart attack, hypertension, diabetes, anxiety & depression to almost every illness & diseases.

Comparison Study with Watch_Pat 100 after one week treatment with ZHT

Subject One


Subject Two

Current main-stream treatment options are unsatisfactory, and the entire world is looking for a better or best solution.

This market is one of the most explosive and largely untapped markets.

Unlike other therapies currently used for sleep apnea, ZHT (Zhou's hypoxicology Therapy) identifies the root causes of sleep apnea, ZHT employs human natural power, human systemic defense reflexes, volitional resuscitations to eliminate and relieve not only sleep apnea but also many other intermittent hypoxia related health problems.

Hypoxia (mild oxygen deprivation) has been identified as the main cause of almost every major illness. Hypoxia has been called the “Hidden and invisible Killer”. Dr. Zhou’s Hypoxicology Therapy (ZHT) is a simple but powerful technique. This is a revolutionary, non-surgical and non-invasive therapy with unprecedented clinical results in less than 5 - 20 minutes, measurable results with pulse oximeter in 5-10 minutes and many other clinical means.

ZHT provides for immediate relief without any need of equipment, breathing device(s) and/or supplement oxygen. ZHT is not for severe hypoxia. However, because it opens up the upper airway, it provides powerful and fast relief for mild hypoxia, the most mysterious cause of illness.

When the ZHT Technique is used in conjunction with standard, conventional medical care & chiropractic therapy, it can provide unprecedented clinical results.

Based currently published research and ZHT clinical observations, ZHT may have potential to provide therapeutic values for diabetes, cancers, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS) and many more sleep disordered breathing (SDB) and chronic intermittent hypoxia related major illness and diseases.

SleepApneaUSA.net, founded by Dr. Jin Zhou, relied upon the latest research and clinically developed ZHT - Zhou's Hypoxicology Therapy to discover a possible cure for sleep apnea and provide an alternative care to those who can't tolerate CPAP,"sleeping mask".

ZHT in News Introduction What Is ZHT? ZHT History Science for ZHT ZHT, Sex & Heart Clinical Applications ZHT Unlimited ZHT Future ZHT for USA
 

9/11 Health Rx | Sleep Apnea | ZHT for Apnea | Investors l Partners l Providers  | About us
 Sleep Apnea News | Sleep Apnea Research | ZHT News l ZHT in News l ZHT Introduction 
 What Is ZHT? | ZHT History | Science for ZHT | ZHT Clinical | ZHT Unlimited l ZHT Future
 ZHT, Sex & Heart | ZHT for USA | | Disclaimer | ZHT Home

Copyright ⓒ 2005-6  - Jin Zhou, SleepApneaUSA.net. All rights reserved

1260 Bamberg Ct., Hanover Park, IL 60133
Tel: 630-736-2974, Fax: 630-736-1439